
Opinion|Videos|May 7, 2024
Managing Adverse Events Associated with HE Therapies
Ralph J. Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
3
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
4
A First-of-Its-Kind All-Oral Option Receives FDA Approval for Newly Diagnosed AML
5
































































































































